Gilpin Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$411 Sell
30
-9
-23% -$123 ﹤0.01% 908
2026
Q2
$529 Buy
+39
New +$466 ﹤0.01% 653
2026
Q1
– Sell
-24
Closed -$173 – 1055
2025
Q4
$173 Buy
+24
New +$190 ﹤0.01% 700

Other funds holding OGN

Gilpin Wealth Management's OGN Position: Q3 2026 in Review

Gilpin Wealth Management reduced its Organon & Co (OGN) stake by 23% in Q3 2026, selling an estimated $123 and leaving 30 shares worth $411. The position accounts for ﹤0.01% of the portfolio, ranked #908.

Gilpin Wealth Management first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $529 in Q2 2026. 37 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Gilpin Wealth Management held 30 shares of Organon & Co worth $411 as of Q3 2026.
  • Gilpin Wealth Management sold 9 Organon & Co shares in Q3 2026, an estimated $123.
  • Organon & Co made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #908 holding.
  • Gilpin Wealth Management first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
  • Gilpin Wealth Management's Organon & Co position peaked at $529 in Q2 2026.
  • 37 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.